Pinheiro, I.; Barberá, A.; Raurell, I.; Estrella, F.; de Leeuw, M.; Bolca, S.; Gottardi, D.; Horscroft, N.; Possemiers, S.; Salcedo, M.T.;
et al. A Nine-Strain Bacterial Consortium Improves Portal Hypertension and Insulin Signaling and Delays NAFLD Progression In Vivo. Biomedicines 2022, 10, 1191.
https://doi.org/10.3390/biomedicines10051191
AMA Style
Pinheiro I, Barberá A, Raurell I, Estrella F, de Leeuw M, Bolca S, Gottardi D, Horscroft N, Possemiers S, Salcedo MT,
et al. A Nine-Strain Bacterial Consortium Improves Portal Hypertension and Insulin Signaling and Delays NAFLD Progression In Vivo. Biomedicines. 2022; 10(5):1191.
https://doi.org/10.3390/biomedicines10051191
Chicago/Turabian Style
Pinheiro, Iris, Aurora Barberá, Imma Raurell, Federico Estrella, Marcel de Leeuw, Selin Bolca, Davide Gottardi, Nigel Horscroft, Sam Possemiers, MarÃa Teresa Salcedo,
and et al. 2022. "A Nine-Strain Bacterial Consortium Improves Portal Hypertension and Insulin Signaling and Delays NAFLD Progression In Vivo" Biomedicines 10, no. 5: 1191.
https://doi.org/10.3390/biomedicines10051191
APA Style
Pinheiro, I., Barberá, A., Raurell, I., Estrella, F., de Leeuw, M., Bolca, S., Gottardi, D., Horscroft, N., Possemiers, S., Salcedo, M. T., Genescà , J., Martell, M., & Augustin, S.
(2022). A Nine-Strain Bacterial Consortium Improves Portal Hypertension and Insulin Signaling and Delays NAFLD Progression In Vivo. Biomedicines, 10(5), 1191.
https://doi.org/10.3390/biomedicines10051191